LUNAR ECLIPSE REVISITED by Kurt Garrett 12/21/2010

All the essentials needed for a night/morning observing the 2010 lunar eclipse in the northern hemisphere.
A  picture is worth a thousand words:

Restore Science to Its Rightful Place...by Kurt A. Garrett

I stood in the frigid cold on top of the US Grant Memorial that balmy day when President Obama proclaimed during his inaugural address to the nation:

"For everywhere we look, there is work to be done.  The state of our economy calls for action, bold and swift.  And we will act, not only to create new jobs, but to lay a new foundation for growth.  We will build the roads and bridges, the electric grids and digital lines that feed our commerce and bind us together.  We'll restore science to its rightful place, and wield technology's wonders to raise health care's quality and lower its cost.  We will harness the sun and the winds and the soil to fuel our cars and run our factories.  And we will transform our schools and colleges and universities to meet the demands of a new age.  All this we can do.  All this we will do."

The challenge and call was clear, besides our normal citizenship we (scientists) were called to "wield technology's wonders…"  I agree with the president: this we can do, this we will do.

Who Is Responsible for Containing The Spread of Nosocomial Infections and MRSA in Healthcare Facilities?

Kurt Garrett pm on November 29th, 2010 :

Nosocomial diseases are manageable while the cost of lives and resources increase, who is courageous enough to step outside the box to evaluate new technologies?

Hank Campbell 4:51pm on December 3rd, 2010 :
What does that even mean? It isn't like millions of people are in boxes in hospitals asking to let patients be infected.


Kurt Garrett 9:42pm on December 7th, 2010 :

It is the responsibility of health professionals to provide safe service to consumers. It is unthinkable that nosocomial infections for cardiac and neurological surgeries are more than 50%. Consider this: what professional team in any industry would allow such high failures? Disinfection methods and technologies exist. Consequently, when these are not employed we should not expect changes in the rate of infection of the types mentioned.

_____________________________________________________________________

 To Be Continued.

A Board Discussion about Infections in Health Facilities found at http://www.science20.com/

 

HPUV™: A Breakthrough inTechnology by Dr. John Rennick, MD

Sometimes people are fortunate enough to witness a breakthrough in science or technology in their lifetime. Significant breakthroughs have had a tremendous positive impact on mankind such as the discovery of penicillin and the discovery of X-rays.

                I believe that I have been fortunate enough to be one of those people after being shown some of the applications of HPUV. The ability to use this technology for disinfection and other areas in the field of medicine is absolutely incredible. The early current research has demonstrated unprecedented and never before seen utilization of that part of the light spectrum.

                 I have reviewed research done with the HPUV technology that has been substantiated by well-known and well-respected academic medical centers. The research was done on several significant, harmful, deadly, pathogenic bacterial organisms, including Pseudomonas, Klebsiella, and Staphylococcus, and a pathogenic viral organism, Herpes Simplex. The HPUV technology successfully eradicated all of these organisms. The implications of these results are remarkable with the potential for having the most impact of anything discovered within the last 50 to 100 years, especially since there are no harmful or detrimental effects on the environment.     

HPUV™ Rapid Inactivation of Herpes Simplex Virus (HSV) by Kurt Garrett

Herpes simplex Test at UNC-CH

The HSV test validated the high efficacy of HPUV™ and according to Dr. Bachenheimer, gave the fastest performance in his experience, one million colonies inactivated in 3 seconds.


                                                 TABLE 1. Virus HSV Inactivation Table


             5.48 X 103 pfu/well            5.48 X 102 pfu/well                  5.48 X 101 pfu/well

0.1                                                                                                        33

0.2                                                                                                        32

3.0                                                                                                        35

30.0                                                                            0

60.0                                                                            0

90.0                                                                            0

120.0                          0

300.0                          0

730.0                          0


We can realize opportunities for HPUV™ to increase the breath of scientific knowledge by commercializing a number of related products. Researchers will find usefulness in our product/instruments that will give them the capacity to routinely and easily disrupt DNA. They will marvel at the possibility of manipulating various types of biological materials especially in their efforts to engineer machines for a myriad of medical and scientific endeavors.

HPUV™ Challenges Conventional Medical & Science Wisdom by Kurt A. Garrett November 2010

I knew I was facing a steep incline in getting some people to see my vision when a former Director of the NC Biotechnology Center told me that what I was doing "...is not biotechnology" and a Cancer Center Director told me that I had "...things figured wrong". I rebounded a year later and found the inquisitiveness and gentle nature of Dr. Steve Bachenheimer, a microbiologist, who entertained my request to test HPUV™. The results were a landmark, HPUV™ inactivated one million colonies of herpes simplex virus, HSV, in 3 seconds! Since that day the device has not met a microbial target it could not rapidly inactivate. But the highly efficient inactivation was only a proof of concept for a much larger vision for HPUV™. Biotechnology and medical treatment offered immense landscapes for development of novel devices, treatment, diagnostics and new insight. The gap of medical and scientific information to be garnered from HPUV™ is still available.

Conventional thinking has been slow to accept HPUV™'s promise. Instead, those contacted have been unwilling to collaborate or continue proof of concepts. While the cost of development is minimal, ask Bachenheimer, and the proposals are simple, nebulous excuses or 'sudden loss of interest' following confidential disclosures dash hopes of going forward. Until there is a willingness to evaluate unconventional technologies like HPUV™ the poor state of managing infection costs in the billions annually, illness and loss of life described below will persist.

Dr. Bachenheimer has retired and what a shame because open minds are hard to find.



Nosocomial Infection Statistics4.5 hospital acquired infections per 100 admitted people
1.7 million people infected per year
99,000 people die each year (6%)
Estimated as low as $5.7 to as high as $45 billion in medical cost per year
Coronary artery disease ~ $17.5 billion
Congestive heart failure ~ $11.2 billion
Stroke ~ $6.7 billion
Diabetes mellitus with complications ~ 4.2 billion

Pseudomona aeruginosa
136,000 people infected via HAIs (~8000 deaths)
Also infects immunocompromised patients
-Chemotherapy
-Cystic fibrosis
-AIDS
Plants (lettuce, beans, etc)
Animals (mice, insects, worm, etc.)

HPUV™ : Effective Against Nosocomial Infections by Kurt A. Garrett

The article listed below is an example of unusual circumstances. But then similar and worse circumstances are not uncommon. Extrapolate the idea and we all can remember helpless feelings from the anthrax sporing. My small company is not standing by idle. We are having success at rapidly and effectively inactivating nosocomial aquired infections at greater than 2-3 log reductions in seconds! We are seeking collaboration with private investigators who want to commercialize new medical products and services. Contact: kurtgarrett@hpuvinc.com or fax:(919)546.8258.

FAYETTEVILLE, N.C. — A tough strain of skin infection that's called the “Super Bug” has become the most common form of skin infection among adult patients in hospitals nationwide, health officials say, but it can prey on people big and small.

One blister showed up on Emma Berrier’s forehead, then another on her chin. Celia Berrier took her 6-month-old daughter to the doctor.

"He didn't even need to do a culture. He just knew it was MRSA," Celia said Wednesday.

It’s pronounced MER-sah and stands for “methicillin-resistant Staphylococcus aureus,” a tough strain of staph infection unfazed by many antibiotics.

Emma’s mom believes Emma caught MRSA from another child whose MRSA has worsened.

"It progressed and has moved to other parts of his body, and he's just very ill,” Berrier said.

MRSA usually infects the skin and causes large pimples or boils. It can, however, enter through wounds, spread through the bloodstream and even infect the lungs.

"The [bacteria] is everywhere. It's on the skin, in the nose" normally, said Dr. Lan Tran-Phu of the Cumberland County Health Department.